Infection as a cause of type 1 diabetes?

Current Opinion in Rheumatology

Volumn 24, Issue 4, 2012, Pages 417-423

  Christen, Urs ^a   Bender, Christine ^a   Von Herrath, Matthias G ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

chemokines; inflammation; molecular mimicry; rat insulin promoter lymphocytic choriomeningitis virus model; regulatory T cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOCHROME P450 2D6; GLUTAMATE DECARBOXYLASE 65; INSULIN; PROTEIN VP7; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

APOPTOSIS; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CAMPYLOBACTER JEJUNI; COXSACKIE VIRUS B; CYTOMEGALOVIRUS INFECTION; ENTEROVIRUS INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR MIMICRY; MUMPS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ROTAVIRUS INFECTION; RUBELLA VIRUS; STREPTOCOCCUS PYOGENES; VIRUS INFECTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENTEROVIRUS INFECTIONS; EVIDENCE-BASED MEDICINE; HUMANS; ISLETS OF LANGERHANS; MOLECULAR MIMICRY; VIRUS DISEASES;

EID: 84862127763     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283533719     Document Type: Review

References (68)

1. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342:d35.
2. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32:457-467.
3. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32:468-478.
4. Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Natur 1964; 98:129-149.
5. Oldstone MBA. Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 1989; 145:127-136.
6. Christen U, Hintermann E, Holdener M, et al. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun 2010; 34:38-44.
7. Tracy S, Drescher KM, Chapman NM. Enteroviruses and type 1 diabetes. Diabetes Metab Res Rev 2011; 27:820-823.
8. Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49:1319-1324. (Pubitemid 30624232)
9. Hyoty H, Leinikki P, Reunanen A, et al. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diab Res 1988; 9:111-116. (Pubitemid 19089947)
10. Gale EA. Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia 2008; 51:1559-1566.
11. Pak CY, Eun HM, McArthur RG, et al. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988; 2:1-4.
12. Al-Hello H, Paananen A, Eskelinen M, et al. An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9. J Gen Virol 2008; 89:1949-1959.
13. Dotta F, Censini S, Van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104:5115-5120. (Pubitemid 47186185)
14. Yoon J-W, Austin M, Onodera T, et al. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179. (Pubitemid 9191515)
15. Chatterjee NK, Nejman C, Gerling I. Purification and characterization of a strain of coxsackievirus B4 of human origin that induces diabetes in mice. J Med Virol 1988; 26:57-69.
16. Elshebani A,Olsson A, Westman J, et al. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 2007; 124:193-203. (Pubitemid 46216572)
17. Andreoletti L, Hober D, Hober-Vandenberghe C, et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997; 52:121-127. (Pubitemid 27239308)
18. Schulte BM, Bakkers J, Lanke KH, et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 2010; 23:99-104.
19. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346:221-223.
20. Lonnrot M, Salminen K, Knip M, et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 2000; 61:214-220. (Pubitemid 30257246)
21. Yoon JW, Austin M, Onodera T, et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179. (Pubitemid 9191515)
22. Richardson SJ, Willcox A, Bone AJ, et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-1151.
23. Richardson SJ, Willcox A, Hilton DA, et al. Use of antisera directed against dsRNA to detect viral infections in formalin-fixed paraffin-embedded tissue. J Clin Virol 2010; 49:180-185.
24. Stene LC, Oikarinen S, Hyoty H, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59:3174-3180.
25. Simonen-Tikka ML, Pflueger M, Klemola P, et al. Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 2011; 54:2995-3002.
26. Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011; 34:151-155.
27. Lempainen J, Tauriainen S, Vaarala O, et al. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diab Metab Res Rev 2011; doi: 10.1002/dmrr.1294.
28. Srinivasappa J, Saegusa J, Prabhakar BS, et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986; 57:397-401. (Pubitemid 16147963)
29. Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 2004; 40:1113-1120. (Pubitemid 38221193)
30. Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol 2004; 25:61-66. (Pubitemid 38167486)
31. Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibodymediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9:914-920. (Pubitemid 36889935)
32. Atkinson MA, Bowman MA, Campbell L, et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulindependent diabetes. J Clin Invest 1994; 94:2125-2129. (Pubitemid 24348254)
33. Horwitz MS, Bradley LM, Harbertson J, et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4:781-785. (Pubitemid 28331018)
34. Honeyman MC, Stone NL, Falk BA, et al. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010; 184:2204-2210.
35. Oldstone MBA, Nerenberg M, Southern P, et al. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of antiself (virus) immune response. Cell 1991; 65:319-331. (Pubitemid 121006061)
36. von Herrath MG, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994; 1:231-242.
37. Christen U, Edelmann KH, McGavern DB, et al. A viral epitope that mimics a self-antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004; 114:1290-1298. (Pubitemid 40385300)
38. Holdener M, Hintermann E, Bayer M, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008; 205:1409-1422. (Pubitemid 351831496)
39. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47:737-745. (Pubitemid 351280742)
40. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38:1250-1257. (Pubitemid 37314834)
41. Amano K, Leung PS, Rieger R, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174:5874-5883. (Pubitemid 40593233)
42. Wakabayashi K, Lian ZX, Leung PS, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48:531-540.
43. Christen U, Benke D, Wolfe T, et al. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 2004; 113:74-84. (Pubitemid 38541634)
44. Filippi CM, Estes EA, Oldham JE, et al. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009; 119:1515-1523.
45. Diana J, Brezar V, Beaudoin L, et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 2011; 208:729-745.
46. Ehlers S, Kaufmann SH. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: lifestyle changes affecting the hostenvironment interface. Clin Exp Immunol 2010; 160:10-14.
47. Filippi CM, von Herrath MG. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: viruses, autoimmunity and immunoregulation. Clin Exp Immunol 2010; 160:113-119.
48. Chatenoud L, You S, Okada H, et al. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis. Clin Exp Immunol 2010; 160:106-112.
49. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988; 239:500-502. (Pubitemid 18084314)
50. Christen U, von Herrath MG. Infections and autoimmunity-good or bad? J Immunol 2005; 174:7481-7486.
51. Tracy S, Drescher KM, Chapman NM, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002; 76:12097-12111. (Pubitemid 35304309)
52. Kanno T, Kim K, Kono K, et al. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 2006; 80:5637-5643.
53. Schulte BM, Kramer M, Ansems M, et al. Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes 2010; 59:1182-1191.
54. Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferoninduced helicase (IFIH1) region. Nat Genet 2006; 38:617-619. (Pubitemid 43927300)
55. Shigemoto T, Kageyama M, Hirai R, et al. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009; 284:13348-13354.
56. McCartney SA, Vermi W, Lonardi S, et al. RNA sensor-induced type I IFN prevents diabetes caused by a beta cell-tropic virus in mice. J Clin Invest 2011; 121:1497-1507.
57. Heinig M, Petretto E, Wallace C, et al. A trans-acting locus regulates an antiviral expression network and type 1 diabetes risk. Nature 2010; 467:460-464.
58. Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol 2011; 9:254-264.
59. Ellerman KE, Richards CA, Guberski DL, et al. Kilham rat triggers T-celldependent autoimmune diabetes in multiple strains of rat. Diabetes 1996; 45:557-562. (Pubitemid 26140537)
60. Tirabassi RS, Guberski DL, Blankenhorn EP, et al. Infection with viruses from several families triggers autoimmune diabetes in LEW-1WR1 rats: prevention of diabetes by maternal immunization. Diabetes 2010; 59:110-118.
61. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6:382-427. (Pubitemid 23306593)
62. Tracy S, Drescher KM, Jackson JD, et al. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010; 20:106-116.
63. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol 2011; 12:5-9.
64. Wolden-Kirk H, Overbergh L, Christesen HT, et al. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011; 347:106-120.
65. Gregori S, Giarratana N, Smiroldo S, et al. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002; 51:1367-1374. (Pubitemid 34826601)
66. Decallonne B, Van Etten E, Overbergh L, et al. 1Alpha, 25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in nonobese diabetic (NOD) mice through dendritic cells. J Autoimmun 2005; 24:281-289. (Pubitemid 40775852)
67. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60:1624-1631.
68. Nejentsev S, Cooper JD, Godfrey L, et al. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 2004; 53:2709-2712. (Pubitemid 39299283)